Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis

被引:0
|
作者
Silverberg, Jonathan, I [1 ]
Hong, H. Chih-ho [2 ,3 ]
Thyssen, Jacob P. [4 ]
Calimlim, Brian M. [5 ]
Lee, Wan-Ju [5 ]
Teixeira, Henrique D. [5 ]
Collins, Eric B. [6 ]
Crowell, Marjorie M. [6 ]
Johnson, Scott J. [6 ]
Armstrong, April W. [7 ]
机构
[1] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[2] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[3] Prob Med Res, Surrey, BC, Canada
[4] Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark
[5] AbbVie Inc, N Chicago, IL USA
[6] Medicus Econ LLC, Boston, MA USA
[7] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA USA
关键词
atopic dermatitis; moderate-to-severe; targeted therapies; comparative efficacy; network meta-analysis;
D O I
10.1093/bjd/ljad162.018
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
393
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Huang, Yuanjie
    Cai, Limin
    Wu, Xuerui
    Chen, Chen
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 725 - 733
  • [22] Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Lin, Jinger
    Luo, Min
    Zhuo, Qianwei
    Chen, Nuo
    Zhang, Haosong
    Han, Yue
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Is antibiotics prescription needed in infants with topical corticosteroids treatment for moderate-to-severe atopic dermatitis?
    Liu, Ying
    Zhou, Qian
    Dai, Wenkui
    Wang, Shan
    Liang, Yuan
    Li, Yinhu
    Shen, Chunping
    Li, Dongfang
    Li, Yunzhu
    Jiao, Lei
    Bian, Yawei
    Li, Shuaicheng
    Tang, Yi-Wei
    Ma, Lin
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [24] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Luis Puig
    Matthias Augustin
    Dermatology and Therapy, 2021, 11 : 885 - 905
  • [25] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Puig, Luis
    Augustin, Matthias
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 885 - 905
  • [26] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
  • [27] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Wang, Fa-Ping
    Tang, Xiao-Ju
    Wei, Chuan-Qi
    Xu, Lin-Rui
    Mao, Hui
    Luo, Feng-Ming
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) : 190 - 198
  • [28] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Meher, Bikash Ranjan
    Mohanty, Rashmi Ranjan
    Padhy, Biswa Mohan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2335 - 2343
  • [29] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Zeng, Linxi
    Feng, Sen
    Yao, Lulu
    Wang, Bin
    Zhang, Guoqiang
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
  • [30] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, Bader
    Alzahrani, Ziyad
    Samarkandy, Sahal
    Aman, Abdullah
    Jfri, Abdulhadi
    FRONTIERS IN MEDICINE, 2023, 9